European Bronchitis Treatment Market 2020 Size, Growth Analysis Report, Forecast to 2026

European bronchitis treatment market is projected to grow at a significant CAGR of around 3.5% during the forecast period (2020-2026). The market for bronchitis treatment in European region is expected to project a modest growth during the forecast period, backed by the rising prevalence of lung related diseases in the Western European nations, such as UK. As per the European Lung Foundation, around 16.5 million cases of acute bronchitis are registered every year in the region. Moreover, the bronchiolitis is one of the most common causes of hospital admissions in the first 12 months of children, leading to the growth of the bronchitis treatment market among children in the country.

To Request a Sample of our Report on European Bronchitis Treatment Market: https://www.omrglobal.com/request-sample/europe-bronchitis-treatment-market

The well-developed infrastructure of Europe has attracted the attention of global market players to expand their presence in the region, which in turn, is offering growth to the market. Moreover, European Lung Foundation is engaged in several research projects, funded by the European Union (EU). For instance, FRESH AIR is an EU Horizon 2020 project that has a goal of improving the health of individuals that are at risk or are currently dealing with chronic lung conditions in European countries that have limited resources of treatment, such as Vietnam, Uganda, Greece, and Kyrgyz Republic. These projects are expected to offer growth to the bronchitis treatment market in the region during the forecast period.

(Get 15% Discount on Buying this Report)
A full Report of European Bronchitis Treatment Market is Available at: https://www.omrglobal.com/industry-reports/europe-bronchitis-treatment-market

European Bronchitis Treatment Market – Segmentation

By Technology

• Medication
• Antibiotics
• Anti-inflammatory drugs
• Bronchodilators
• Others (Mucolytics)
• Oxygen Therapy

European Bronchitis Treatment Market – Segmentation by Geography

• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe

Company Profiles

• Abbott Laboratories
• Bayer AG
• Boehringer Ingelheim International GmbH
• Cipla Ltd.
• GlaxoSmithKline PLC
• Lupin Pharmaceuticals, Inc.
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi SA
• Teva Pharmaceutical Industries Ltd.

Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/europe-bronchitis-treatment-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.